Gene expression predictors in breast cancer: current status, limitations and perspectives.


Breast cancer is characterised by a wide heterogeneity regarding outcome and drug sensitivity. A better prediction of these two parameters at the individual level should improve patient management and therefore also improve both the quality of life and the overall survival of the patient. Several molecular predictors for prognosis (MammaPrint or Oncotype DX… (More)
DOI: 10.1016/j.ejca.2008.09.011


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.